Sigadax DPM Tablet is an advanced oral anti-diabetic combination containing dapagliflozin, metformin, and sitagliptin. Dapagliflozin works as an SGLT2 inhibitor, promoting glucose excretion through urine; metformin reduces hepatic glucose production and improves insulin sensitivity; while sitagliptin enhances incretin activity, boosting insulin secretion and lowering glucagon. This triple therapy provides comprehensive glycemic control in patients with type 2 diabetes mellitus. It helps reduce HbA1c levels, manage postprandial sugar spikes, and improve overall metabolic balance. Additionally, dapagliflozin supports weight loss and reduces cardiovascular risks. Regular use, along with diet and exercise, improves long-term diabetes management. It is especially useful for patients requiring multi-targeted therapy for better blood sugar control.

Dosage & How to Use